Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Citi
US Department of Justice
Covington
US Army
Julphar
Accenture
Novartis
Healthtrust

Generated: February 23, 2018

DrugPatentWatch Database Preview

ETODOLAC Drug Profile

« Back to Dashboard

Which patents cover Etodolac, and what generic alternatives are available?

Etodolac is a drug marketed by Ani Pharms Inc, Apotex, Chartwell Molecules, Eci Pharms Llc, Idt Australia Ltd, Mylan, Sandoz, Taro, Watson Labs, Actavis Elizabeth, Teva, Watson Labs Florida, Zydus Pharms Usa Inc, Apotex Inc, Ivax Sub Teva Pharms, Mylan Pharms Inc, Oxford Pharms, Ranbaxy Labs Ltd, and Taro Pharm Inds. and is included in thirty-three NDAs.

The generic ingredient in ETODOLAC is etodolac. There are twenty-three drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the etodolac profile page.
Drug patent expirations by year for ETODOLAC
Pharmacology for ETODOLAC
Medical Subject Heading (MeSH) Categories for ETODOLAC

US Patents and Regulatory Information for ETODOLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms ETODOLAC etodolac TABLET;ORAL 074883-001 Feb 28, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Florida ETODOLAC etodolac TABLET, EXTENDED RELEASE;ORAL 075829-001 Nov 30, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd ETODOLAC etodolac TABLET;ORAL 075226-001 Nov 24, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva ETODOLAC etodolac TABLET;ORAL 075009-002 Dec 28, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc ETODOLAC etodolac TABLET;ORAL 075104-001 Feb 6, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd ETODOLAC etodolac TABLET;ORAL 075226-002 Nov 24, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm Inds ETODOLAC etodolac TABLET;ORAL 075074-001 Mar 11, 1998 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs ETODOLAC etodolac TABLET;ORAL 074892-001 Apr 16, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro ETODOLAC etodolac TABLET, EXTENDED RELEASE;ORAL 076174-003 Mar 13, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Florida ETODOLAC etodolac TABLET, EXTENDED RELEASE;ORAL 075829-002 Nov 30, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
QuintilesIMS
Express Scripts
Healthtrust
Fish and Richardson
Deloitte
Chubb
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot